← All diseases

Genetic syndromes and other conditions

Silver-Russell syndrome (SRS)

A genetic condition with slow growth before and after birth. The baby is born small, and feeding problems are common.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Genetic syndromes and other conditions” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

The setting of the genes that control growth is disturbed. These genes are on chromosomes 11 and 7. In most people the problem is on chromosome 11. In about a third of people, no cause is found.

Which symptoms can occur?

Symptoms vary from person to person. The following may be seen:

  • Low birth weight and slow weight gain
  • A head that looks large for the body
  • One side of the body being larger
  • Feeding difficulties, vomiting and reflux
  • Repeated low blood sugar
  • A small, triangular face and a prominent forehead
  • A short, curved little finger
  • Delay in movement and speech

How is it diagnosed?

The diagnosis is based on examination findings and a scoring system. Genetic tests look at chromosomes 11 and 7. These tests confirm the diagnosis in about 60 percent of people.

Treatment and care

Treatment is planned according to the symptoms and is provided by a team. In the first years the aim is to get enough calories. If needed, a feeding tube is used, but overfeeding is avoided. Blood sugar is monitored. Growth hormone treatment can support height and muscle development. The timing of puberty and bone age are followed by a hormone specialist. If needed, support with speech and movement is given. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

In most children the change is new and no one else in the family is affected. Rarely, more than one person in the family is affected. In some families dominant inheritance is seen. The risk depends on the type of genetic change and which parent it comes from. Genetic counselling is recommended.

Source: MedlinePlus Genetics: Silver-Russell syndrome · NORD: Russell-Silver Syndrome

Key facts

How common is it?
New cases per year: 1-5 per 10 000 (Europe) · Prevalence: 1-9 per 1 000 000 (Europe)
When does it usually start?
Before birth, Newborn period

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Home care and medical devices · Home health service, oxygen and respiratory device reports, wheelchairs and orthoses, power outage notification, emergency plan.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Silver-Russell

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Genetic syndromes and other conditions: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:813

No separate ICD-11 code; WHO classifies this disease under: LD2F.1Y

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.